Jeanine Ballard
Papers
1
Total Citations
6
H-Index
1
About
Jeanine Ballard is a translational pharmacologist whose work focuses on the pharmacokinetic/pharmacodynamic (PK/PD) modeling of HIV latency reversal, a critical frontier in the quest to cure HIV. Her research centers on using automated, high-throughput platforms to evaluate novel histone deacetylase inhibitors (HDACis) as latency-reversing agents, aiming to "shock and kill" the dormant viral reservoir that persists despite antiretroviral therapy. Ballard’s key contribution lies in developing sophisticated in vitro PK/PD models that bridge preclinical drug screening and clinical application, enabling more precise prediction of how HDACis behave in the body to reactivate latent HIV. Her most-cited paper (2021, 6 citations) demonstrates this approach, highlighting the potential of automated systems to accelerate the discovery of effective latency reversal strategies. While her citation count is modest, her work is foundational in a niche but urgent area of HIV eradication research, offering a rigorous framework for evaluating novel compounds. Ballard’s achievements underscore her role in advancing the precision pharmacology needed to overcome the latent reservoir—a major barrier to a functional cure.
Research Focus
Key Achievements
Top Papers
- 1